To include your compound in the COVID-19 Resource Center, submit it here.

Regeneron leads big data sequencing effort

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced a consortium of six biotech and pharmas to speed up exome sequencing of genetic data from samples in the UK Biobank.

UK Biobank debuted in 2012

Read the full 302 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE